• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

静脉侵犯对pT1-3N0cM0期胃癌术后复发的影响

The Impact of Venous Invasion on the Postoperative Recurrence of pT1-3N0cM0 Gastric Cancer.

作者信息

Imai Yasuo, Kurata Yoshihiro, Ichinose Masanori

机构信息

Department of Diagnostic Pathology, Ota Memorial Hospital, SUBARU Health Insurance Society, 455-1 Oshima, Ota City 373-8585, Gunma, Japan.

Department of Digestive Surgery, Shioya Hospital, International University of Health and Welfare, Yaita City 329-2145, Tochigi, Japan.

出版信息

J Pers Med. 2023 Apr 26;13(5):734. doi: 10.3390/jpm13050734.

DOI:10.3390/jpm13050734
PMID:37240905
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10221240/
Abstract

The impact of venous invasion (VI) on postoperative recurrence in pathological (p)T1-3N0 clinical (c)M0 gastric cancer (GC) remains unclear. We investigated the association of VI grade with prognosis in 94 (78 stage I and 16 stage IIA) patients. VI was graded during pathological examinations based on the number of VIs per glass slide as follows: v0, 0; v1, 1-3; v2, 4-6; and v3, ≥7. Filling-type invasion in veins with a minor axis of ≥1 mm increased VI grade by 1. Four (4.3%) patients experienced recurrence. Recurrence increased with pT (pT1, 0.0%; pT2, 11.1%; pT3, 18.8%) and VI grade (v0, 0.0%; v1, 3.7%, v2, 14.3%; and v3, 40.0%). Recurrence was significantly more frequent in pT3 than pT1 and in v2 + v3 than v0 ( = 0.006 and 0.005, respectively). Kaplan-Meier curve analyses demonstrated a significant decrease in recurrence-free survival according to pT ( = 0.0021) and VI grade ( < 0.0001). Multivariate Cox analysis revealed a significant association of VI grade with recurrence ( = 0.049). These results suggest that VI grade is a potential recurrence predictor for pT1-3N0cM0 GC. No recurrence can be expected in cases with pT1 or VI grade v0. Adjuvant therapy might be considered for pT3 or VI grade v2 + v3.

摘要

静脉侵犯(VI)对病理分期(p)为T1-3、临床分期(c)为N0、M0的胃癌(GC)术后复发的影响尚不清楚。我们调查了94例(78例I期和16例IIA期)患者中VI分级与预后的相关性。在病理检查期间,根据每张玻片上VI的数量对VI进行分级,具体如下:v0,0个;v1,1-3个;v2,4-6个;v3,≥7个。静脉内短轴≥1 mm的充盈型侵犯使VI分级增加1级。4例(4.3%)患者出现复发。复发率随pT升高(pT1,0.0%;pT2,11.1%;pT3,18.8%)和VI分级升高(v0,0.0%;v1,3.7%;v2,14.3%;v3,4​​0.0%)而增加。pT3期的复发明显比pT1期更频繁,v2 + v3级的复发明显比v0级更频繁(分别为P = 0.006和0.005)。Kaplan-Meier曲线分析表明,根据pT(P = 0.0021)和VI分级(P < 0.0001),无复发生存期显著降低。多因素Cox分析显示VI分级与复发有显著相关性(P = 0.049)。这些结果表明,VI分级是pT1-3N0cM0 GC潜在的复发预测指标。pT1期或VI分级为v0的病例预计不会复发。对于pT3期或VI分级为v2 + v3的病例,可能需要考虑辅助治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ce2/10221240/bb71c9dad926/jpm-13-00734-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ce2/10221240/bb71c9dad926/jpm-13-00734-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ce2/10221240/bb71c9dad926/jpm-13-00734-g001.jpg

相似文献

1
The Impact of Venous Invasion on the Postoperative Recurrence of pT1-3N0cM0 Gastric Cancer.静脉侵犯对pT1-3N0cM0期胃癌术后复发的影响
J Pers Med. 2023 Apr 26;13(5):734. doi: 10.3390/jpm13050734.
2
Risk stratification for predicting postoperative recurrence of gastric cancer by grade of venous invasion.通过静脉侵犯程度对胃癌术后复发进行风险分层。
BMC Gastroenterol. 2023 May 30;23(1):189. doi: 10.1186/s12876-023-02825-0.
3
Risk stratification for predicting postoperative recurrence/metastasis of colorectal cancer by grade of venous invasion coupled with histological subtype.通过静脉侵犯程度和组织学亚型对结直肠癌术后复发/转移进行风险分层。
BMC Gastroenterol. 2022 Feb 23;22(1):79. doi: 10.1186/s12876-022-02163-7.
4
Renal cell carcinoma: vena caval invasion and prognostic factors.肾细胞癌:腔静脉侵犯与预后因素
Eur Urol. 1991;19(4):284-90. doi: 10.1159/000473644.
5
[Survival analysis in renal cell carcinoma with invasion of the vena cava].[伴有腔静脉侵犯的肾细胞癌的生存分析]
Actas Urol Esp. 1991 May-Jun;15(3):247-52.
6
A prospective clinicopathologic study of venous invasion in colorectal cancer.一项关于结直肠癌中静脉侵犯的前瞻性临床病理研究。
Am J Surg. 1991 Sep;162(3):216-22. doi: 10.1016/0002-9610(91)90073-m.
7
Factors associated with early recurrence after curative surgery for gastric cancer.胃癌根治性手术后早期复发的相关因素。
World J Gastroenterol. 2015 May 21;21(19):5934-40. doi: 10.3748/wjg.v21.i19.5934.
8
Association between Lymphovascular Invasion and Recurrence in Patients with pT1N+ or pT2-3N0 Gastric Cancer: a Multi-institutional Dataset Analysis.pT1N+或pT2-3N0期胃癌患者淋巴管侵犯与复发的相关性:一项多机构数据集分析
J Gastric Cancer. 2020 Mar;20(1):41-49. doi: 10.5230/jgc.2020.20.e3. Epub 2020 Jan 20.
9
Prognostic impact of venous invasion in stage IB node-negative gastric cancer.IB 期淋巴结阴性胃癌中静脉侵犯的预后影响。
Gastric Cancer. 2015 Apr;18(2):297-305. doi: 10.1007/s10120-014-0362-2. Epub 2014 Apr 1.
10
Prognostic factors in T1 and T2 squamous cell carcinoma of the thoracic esophagus.胸段食管T1和T2期鳞状细胞癌的预后因素
Arch Surg. 1999 Jan;134(1):50-4. doi: 10.1001/archsurg.134.1.50.

引用本文的文献

1
Harnessing the machine learning and nomogram models: elevating prognostication in nonmetastatic gastric cancer with "double invasion" for personalized patient care.利用机器学习和列线图模型:提升伴有“双侵袭”的非转移性胃癌的预后预测,以实现个性化患者护理。
Eur J Med Res. 2025 Jun 23;30(1):517. doi: 10.1186/s40001-025-02761-7.
2
Identifying high-risk candidates for prolonging progression-free survival in primary gastric carcinoma subject to "double invasion": an analytical approach utilizing lasso-cox regression.识别原发性胃癌“双侵袭”中延长无进展生存期的高危候选者:一种利用套索-考克斯回归的分析方法
BMC Cancer. 2025 Feb 28;25(1):381. doi: 10.1186/s12885-025-13810-z.
3

本文引用的文献

1
Venous Invasion Is a Risk Factor for Recurrence of pT1 Gastric Cancer with Lymph Node Metastasis.静脉侵犯是伴有淋巴结转移的pT1期胃癌复发的一个危险因素。
J Gastrointest Surg. 2022 Apr;26(4):757-763. doi: 10.1007/s11605-021-05238-0. Epub 2022 Jan 10.
2
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
3
A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: the ARTIST 2 trial.
Risk stratification for predicting postoperative recurrence of gastric cancer by grade of venous invasion.
通过静脉侵犯程度对胃癌术后复发进行风险分层。
BMC Gastroenterol. 2023 May 30;23(1):189. doi: 10.1186/s12876-023-02825-0.
一项比较辅助性单药 S1、S-1 联合奥沙利铂与术后 S-1 和奥沙利铂放化疗在接受 D2 根治术后淋巴结阳性胃癌患者中的随机 III 期临床试验:ARTIST2 试验。
Ann Oncol. 2021 Mar;32(3):368-374. doi: 10.1016/j.annonc.2020.11.017. Epub 2020 Dec 3.
4
Prognostic Factors in Stage IB Gastric Cancer after Surgical Resection.ⅠB期胃癌手术切除后的预后因素
J Gastric Cancer. 2020 Sep;20(3):328-336. doi: 10.5230/jgc.2020.20.e30. Epub 2020 Sep 23.
5
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial.氟尿嘧啶+亚叶酸、奥沙利铂和多西紫杉醇与氟尿嘧啶或卡培他滨+顺铂和表柔比星用于局部晚期可切除胃或胃食管交界处腺癌的围手术期化疗(FLOT4):一项随机、2/3 期试验。
Lancet. 2019 May 11;393(10184):1948-1957. doi: 10.1016/S0140-6736(18)32557-1. Epub 2019 Apr 11.
6
Addition of Docetaxel to Oral Fluoropyrimidine Improves Efficacy in Patients With Stage III Gastric Cancer: Interim Analysis of JACCRO GC-07, a Randomized Controlled Trial.多西他赛联合口服氟嘧啶可提高 III 期胃癌患者的疗效:JACCRO GC-07 随机对照试验的中期分析。
J Clin Oncol. 2019 May 20;37(15):1296-1304. doi: 10.1200/JCO.18.01138. Epub 2019 Mar 29.
7
Gastric Cancer: Recent Molecular Classification Advances, Racial Disparity, and Management Implications.胃癌:最新分子分类进展、种族差异及其管理启示。
J Oncol Pract. 2018 Apr;14(4):217-224. doi: 10.1200/JOP.17.00025.
8
Prognostic impact of venous invasion in stage IB node-negative gastric cancer.IB 期淋巴结阴性胃癌中静脉侵犯的预后影响。
Gastric Cancer. 2015 Apr;18(2):297-305. doi: 10.1007/s10120-014-0362-2. Epub 2014 Apr 1.
9
Differences in risk factors between patterns of recurrence in patients after curative resection for advanced gastric carcinoma.根治性切除术后晚期胃癌患者复发模式的危险因素差异。
World J Surg Oncol. 2013 May 17;11:98. doi: 10.1186/1477-7819-11-98.
10
Gastric cancer: Classification, histology and application of molecular pathology.胃癌:分类、组织病理学和分子病理学的应用。
J Gastrointest Oncol. 2012 Sep;3(3):251-61. doi: 10.3978/j.issn.2078-6891.2012.021.